Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jul;35(7):642-644.
doi: 10.1038/s41371-020-0378-5. Epub 2020 Jul 9.

Implications of CRISPR/Cas9 system in Hypertension and its related diseases

Durairaj Sekar  1 , Ganesh Lakshmanan  2 , Biruntha M  3
Affiliations

Implications of CRISPR/Cas9 system in Hypertension and its related diseases

Durairaj Sekar et al. J Hum Hypertens. 2021 Jul.
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no conflict of interest.

Figures

Fig. 1
Fig. 1. Represents the CRISPR/CAS9 system editing the genome sequences in the cells.
a Guide RNA is generated in the cells for specific site in the genome. b Cas9 prtein interact with Guide RNA specific sites. c CRISPR/Cas 9 complex introduce double stranded break in the target site.
See this image and copyright information in PMC

References

    1. Rodríguez-Rodríguez DR, Ramírez-Solís R, Garza-Elizondo MA, Garza-Rodríguez ML, Barrera-Saldaña HA. Genome editing: a perspective on the application of CRISPR/Cas9 to study human diseases (Review) Int J Mol Med. 2019;43:1559–74. doi: 10.3892/ijmm.2019.4112. - DOI - PMC - PubMed
    1. Wright AV, Nuñez JK, Doudna JA. Biology and applications of CRISPR systems: harnessing nature’s toolbox for genome engineering. Cell. 2016;164:29–44. doi: 10.1016/j.cell.2015.12.035. - DOI - PubMed
    1. Sekar D. Circular RNA: a new biomarker for different types of hypertension. Hypertens Res. 2019;42:1824–5. doi: 10.1038/s41440-019-0302-y. - DOI - PubMed
    1. Xie N, Zhou Y, Sun Q, Tang B Novel Epigenetic Techniques Provided by the CRISPR/Cas9 System. Stem Cells Int. 2018;2018:7834175. Published 2018 Jul. 10.1155/2018/7834175. - PMC - PubMed
    1. Liu C, Chen CY, Shang QH, Liu J. [Establishment of Ace2 knockout mouse model with CRISPR/Cas9 gene targeting technology] Sheng Li XueBao. 2019;71:588–96. - PubMed

Publication types